Skip to main content
Top
Published in: BMC Palliative Care 1/2012

Open Access 01-12-2012 | Research article

Factors associated with the severity and improvement of fatigue in patients with advanced cancer presenting to an outpatient palliative care clinic

Published in: BMC Palliative Care | Issue 1/2012

Login to get access

Abstract

Background

The aim of this study was to determine factors associated with the severity of cancer related fatigue (CRF) and predictors of improvement of CRF at the first follow-up visit in patients with advanced cancer referred to outpatient palliative care clinic (OPC).

Methods

We reviewed the records of consecutive patients with advanced cancer presenting to OPC. Edmonton Symptom Assessment System (ESAS) scores were obtained at the initial and subsequent visits between January 2003 and December 2008. All patients received interdisciplinary care led by palliative medicine specialists following an institutional protocol. Fatigue improvement was defined as a reduction of ≥2 points in ESAS score relative to the baseline. Descriptive statistics were used to summarize patient characterstics. Univariate analyses were performed and only significant variables were included in multivariate regression analysis to determine factors associated with severity and improvement in CRF.

Results

A total of 1778 evaluable patients were analyzed (median age, 59 years; 52% male). The median time between visits was 15 days. Median fatigue scores on the ESAS were 6 at baseline and 5 at follow-up. Severity of all ESAS items and low serum albumin were associated with fatigue at baseline (p < 0.0001). The improvement of fatigue was observed in 586 patients (33%). The hierarchical model showed that fatigue improved over time (b = −0.009; p = 0.0009). low appetite (odds ratio [OR] = 1.09 per point; p = 0.0113) and genitourinary cancer (OR = 1.74 per point; p = 0.0458) were significantly associated with improvement of fatigue.

Conclusions

CRF is strongly associated with physical and emotional symptoms. Genitourinary cancer and low appetite at baseline were associated with successful improvement of fatigue.
Literature
1.
go back to reference Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J: Evidence Report on the Occurrence, Assessment, and Treatment of Fatigue in Cancer Patients. JNCI Monographs. 2004, 32: 40-50.CrossRef Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J: Evidence Report on the Occurrence, Assessment, and Treatment of Fatigue in Cancer Patients. JNCI Monographs. 2004, 32: 40-50.CrossRef
2.
go back to reference Yennurajalingam S, Bruera E: Palliative Management of Fatigue at the Close of Life. JAMA. 2007, 297: 295-304. 10.1001/jama.297.3.295.CrossRefPubMed Yennurajalingam S, Bruera E: Palliative Management of Fatigue at the Close of Life. JAMA. 2007, 297: 295-304. 10.1001/jama.297.3.295.CrossRefPubMed
3.
go back to reference Piper BF, Cella D: Cancer-Related Fatigue: Definitions and Clinical Subtypes. J Natl Compr Canc Netw. 2010, 8 (8): 958-966.PubMed Piper BF, Cella D: Cancer-Related Fatigue: Definitions and Clinical Subtypes. J Natl Compr Canc Netw. 2010, 8 (8): 958-966.PubMed
4.
go back to reference Minton O, Richardson A, Sharpe M, Hotopf M, Stone P: A Systematic Review and Meta-Analysis of the Pharmacological Treatment of Cancer-Related Fatigue. J Natl Cancer Inst. 2008, 100: 1155-1166. 10.1093/jnci/djn250.CrossRefPubMed Minton O, Richardson A, Sharpe M, Hotopf M, Stone P: A Systematic Review and Meta-Analysis of the Pharmacological Treatment of Cancer-Related Fatigue. J Natl Cancer Inst. 2008, 100: 1155-1166. 10.1093/jnci/djn250.CrossRefPubMed
5.
go back to reference Osta BE, Palmer JL, Paraskevopoulos T, Pei B-L, Roberts LE, Poulter VA, Chacko R, Bruera E: Interval between First Palliative Care Consult and Death in Patients Diagnosed with Advanced Cancer at a Comprehensive Cancer Center. J Palliat Med. 2008, 11: 51-57. 10.1089/jpm.2007.0103.CrossRefPubMed Osta BE, Palmer JL, Paraskevopoulos T, Pei B-L, Roberts LE, Poulter VA, Chacko R, Bruera E: Interval between First Palliative Care Consult and Death in Patients Diagnosed with Advanced Cancer at a Comprehensive Cancer Center. J Palliat Med. 2008, 11: 51-57. 10.1089/jpm.2007.0103.CrossRefPubMed
6.
go back to reference Dalal S, Palla S, Hui D, Nguyen L, Chacko R, Li Z, Fadul N, Scott C, Thornton V, Coldman B, Amin Y, Bruera E: Association Between a Name Change from Palliative to Supportive Care and the Timing of Patient Referrals at a Comprehensive Cancer Center. Oncologist. 2011, 16: 105-111. 10.1634/theoncologist.2010-0161.CrossRefPubMedPubMedCentral Dalal S, Palla S, Hui D, Nguyen L, Chacko R, Li Z, Fadul N, Scott C, Thornton V, Coldman B, Amin Y, Bruera E: Association Between a Name Change from Palliative to Supportive Care and the Timing of Patient Referrals at a Comprehensive Cancer Center. Oncologist. 2011, 16: 105-111. 10.1634/theoncologist.2010-0161.CrossRefPubMedPubMedCentral
7.
go back to reference Osoba D, Rodrigues G, Myles J, Zee B, Pater J: Interpreting the significance of changes in health-related quality-of- life scores. J Clin Oncol. 1998, 16: 139-144.PubMed Osoba D, Rodrigues G, Myles J, Zee B, Pater J: Interpreting the significance of changes in health-related quality-of- life scores. J Clin Oncol. 1998, 16: 139-144.PubMed
8.
go back to reference Joly F, Vardy J, Pintilie M, Tannock IF: Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer. Ann Oncol. 2007, 18: 1935-1942. 10.1093/annonc/mdm121.CrossRefPubMed Joly F, Vardy J, Pintilie M, Tannock IF: Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer. Ann Oncol. 2007, 18: 1935-1942. 10.1093/annonc/mdm121.CrossRefPubMed
9.
go back to reference Elsayem A, Buera E: The M.D. Anderson symptom control and palliative care handbook. Houston, Printing Services. 2008, USA: University of Health Science Center at Houston Elsayem A, Buera E: The M.D. Anderson symptom control and palliative care handbook. Houston, Printing Services. 2008, USA: University of Health Science Center at Houston
11.
go back to reference Bruera E: KN, Miller MJ, Selmser P, Macmillan K:The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991, 7: 6-9.PubMed Bruera E: KN, Miller MJ, Selmser P, Macmillan K:The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991, 7: 6-9.PubMed
12.
go back to reference Chang VT, Hwang SS, Feuerman M: Validation of the Edmonton Symptom Assessment Scale. Cancer. 2000, 88: 2164-2171. 10.1002/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5.CrossRefPubMed Chang VT, Hwang SS, Feuerman M: Validation of the Edmonton Symptom Assessment Scale. Cancer. 2000, 88: 2164-2171. 10.1002/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5.CrossRefPubMed
13.
go back to reference Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S: The memorial delirium assessment scale. J Pain Symptom Manage. 1997, 13: 128-137. 10.1016/S0885-3924(96)00316-8.CrossRefPubMed Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S: The memorial delirium assessment scale. J Pain Symptom Manage. 1997, 13: 128-137. 10.1016/S0885-3924(96)00316-8.CrossRefPubMed
14.
go back to reference Bush B, Shaw S, Cleary P, Delbanco TL, Aronson MD: Screening for alcohol abuse using the cage questionnaire. Am J Med. 1987, 82: 231-235. 10.1016/0002-9343(87)90061-1.CrossRefPubMed Bush B, Shaw S, Cleary P, Delbanco TL, Aronson MD: Screening for alcohol abuse using the cage questionnaire. Am J Med. 1987, 82: 231-235. 10.1016/0002-9343(87)90061-1.CrossRefPubMed
15.
go back to reference Akechi T, Kugaya A, Okamura H, Yamawaki S, Uchitomi Y: Fatigue and Its Associated Factors in Ambulatory Cancer Patients: A Preliminary Study. J Pain Symptom Manage. 1999, 17: 42-48. 10.1016/S0885-3924(98)00105-5.CrossRefPubMed Akechi T, Kugaya A, Okamura H, Yamawaki S, Uchitomi Y: Fatigue and Its Associated Factors in Ambulatory Cancer Patients: A Preliminary Study. J Pain Symptom Manage. 1999, 17: 42-48. 10.1016/S0885-3924(98)00105-5.CrossRefPubMed
16.
go back to reference Zeng L, Koo K, Zhang L, Jon F, Dennis K, Holden L, Nguyen J, Tsao M, Barnes E, Danjoux C, Sahgal A, Chow E: Fatigue in advanced cancer patients attending an outpatient palliative radiotherapy clinic as screened by the Edmonton Symptom Assessment System. Support Care Cancer. 2012, 30: 1037-1042.CrossRef Zeng L, Koo K, Zhang L, Jon F, Dennis K, Holden L, Nguyen J, Tsao M, Barnes E, Danjoux C, Sahgal A, Chow E: Fatigue in advanced cancer patients attending an outpatient palliative radiotherapy clinic as screened by the Edmonton Symptom Assessment System. Support Care Cancer. 2012, 30: 1037-1042.CrossRef
17.
go back to reference Okuyama T, Akechi T, Shima Y, Sugahara Y, Okamura H, Hosaka T, Furukawa TA, Uchitomi Y: Factors Correlated with Fatigue in Terminally Ill Cancer Patients: A Longitudinal Study. J Pain Symptom Manage. 2008, 35: 515-523. 10.1016/j.jpainsymman.2007.06.014.CrossRefPubMed Okuyama T, Akechi T, Shima Y, Sugahara Y, Okamura H, Hosaka T, Furukawa TA, Uchitomi Y: Factors Correlated with Fatigue in Terminally Ill Cancer Patients: A Longitudinal Study. J Pain Symptom Manage. 2008, 35: 515-523. 10.1016/j.jpainsymman.2007.06.014.CrossRefPubMed
18.
go back to reference Respini D, Jacobsen PB, Thors C, Tralongo P, Balducci L: The prevalence and correlates of fatigue in older cancer patients. Crit Rev Oncol Hematol. 2003, 47 (3): 273-279. 10.1016/s1040-8428(02)00176-2.CrossRefPubMed Respini D, Jacobsen PB, Thors C, Tralongo P, Balducci L: The prevalence and correlates of fatigue in older cancer patients. Crit Rev Oncol Hematol. 2003, 47 (3): 273-279. 10.1016/s1040-8428(02)00176-2.CrossRefPubMed
19.
go back to reference Broeckel JA, Jacobsen PB, Norton J, Balducci L, Lyman GH: Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol. 1998, 16: 1689-1696.PubMed Broeckel JA, Jacobsen PB, Norton J, Balducci L, Lyman GH: Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol. 1998, 16: 1689-1696.PubMed
20.
go back to reference Hwang SS, Chang VT, Rue M, Kasimis B: Multidimensional independent predictors of cancer-related fatigue. J Pain Symptom Manage. 2003, 26: 604-614. 10.1016/S0885-3924(03)00218-5.CrossRefPubMed Hwang SS, Chang VT, Rue M, Kasimis B: Multidimensional independent predictors of cancer-related fatigue. J Pain Symptom Manage. 2003, 26: 604-614. 10.1016/S0885-3924(03)00218-5.CrossRefPubMed
21.
go back to reference Seo Y, Oh H, Seo W: Causal relationships among factors associated with cancer-related fatigue. Eur J Oncol Nurs. 2010, 14: 380-386. 10.1016/j.ejon.2009.09.008.CrossRefPubMed Seo Y, Oh H, Seo W: Causal relationships among factors associated with cancer-related fatigue. Eur J Oncol Nurs. 2010, 14: 380-386. 10.1016/j.ejon.2009.09.008.CrossRefPubMed
22.
go back to reference Yennurajalingam S, Palmer J, Zhang T, Poulter V, Bruera E: Association between fatigue and other cancer-related symptoms in patients with advanced cancer. Support Care Cancer. 2008, 16: 1125-1130. 10.1007/s00520-008-0466-5.CrossRefPubMed Yennurajalingam S, Palmer J, Zhang T, Poulter V, Bruera E: Association between fatigue and other cancer-related symptoms in patients with advanced cancer. Support Care Cancer. 2008, 16: 1125-1130. 10.1007/s00520-008-0466-5.CrossRefPubMed
23.
go back to reference Stone P, Hardy J, Broadley K, Tookman AJ, Kurowska A, A'Hern R: Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br J Cancer. 1999, 79: 1479-1486. 10.1038/sj.bjc.6690236.CrossRefPubMedPubMedCentral Stone P, Hardy J, Broadley K, Tookman AJ, Kurowska A, A'Hern R: Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br J Cancer. 1999, 79: 1479-1486. 10.1038/sj.bjc.6690236.CrossRefPubMedPubMedCentral
24.
go back to reference Jacobsen PB, Garland LL, Booth-Jones M, Donovan KA, Thors CL, Winters E, Grendys E: Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy. J Pain Symptom Manage. 2004, 28: 7-18. 10.1016/j.jpainsymman.2003.11.002.CrossRefPubMed Jacobsen PB, Garland LL, Booth-Jones M, Donovan KA, Thors CL, Winters E, Grendys E: Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy. J Pain Symptom Manage. 2004, 28: 7-18. 10.1016/j.jpainsymman.2003.11.002.CrossRefPubMed
25.
go back to reference Lind M, Vernon C, Cruickshank D, Wilkinson P, Littlewood T, Stuart N, Jenkinson C, Grey-Amante P, Doll H, Wild D: The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. Br J Cancer. 2002, 86: 1243-1249. 10.1038/sj.bjc.6600247.CrossRefPubMedPubMedCentral Lind M, Vernon C, Cruickshank D, Wilkinson P, Littlewood T, Stuart N, Jenkinson C, Grey-Amante P, Doll H, Wild D: The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. Br J Cancer. 2002, 86: 1243-1249. 10.1038/sj.bjc.6600247.CrossRefPubMedPubMedCentral
26.
go back to reference Cella D, Lai J-s, Chang C-H, Peterman A, Slavin M: Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002, 94: 528-538. 10.1002/cncr.10245.CrossRefPubMed Cella D, Lai J-s, Chang C-H, Peterman A, Slavin M: Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002, 94: 528-538. 10.1002/cncr.10245.CrossRefPubMed
27.
go back to reference Munch TN, Zhang T, Willey J, Palmer JL, Bruera E: The Association between Anemia and Fatigue in Patients with Advanced Cancer Receiving Palliative Care. J Palliat Med. 2005, 8: 1144-1149. 10.1089/jpm.2005.8.1144.CrossRefPubMed Munch TN, Zhang T, Willey J, Palmer JL, Bruera E: The Association between Anemia and Fatigue in Patients with Advanced Cancer Receiving Palliative Care. J Palliat Med. 2005, 8: 1144-1149. 10.1089/jpm.2005.8.1144.CrossRefPubMed
28.
go back to reference Stone P, Richards M, A'Hern R, Hardy J: A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol. 2000, 11: 561-567. 10.1023/A:1008331230608.CrossRefPubMed Stone P, Richards M, A'Hern R, Hardy J: A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol. 2000, 11: 561-567. 10.1023/A:1008331230608.CrossRefPubMed
29.
go back to reference Conill C, Verger E, Henríquez I, Saiz N, Espier M, Lugo F, Garrigos A: Symptom prevalence in the last week of life. J Pain Symptom Manage. 1997, 14: 328-331. 10.1016/S0885-3924(97)00263-7.CrossRefPubMed Conill C, Verger E, Henríquez I, Saiz N, Espier M, Lugo F, Garrigos A: Symptom prevalence in the last week of life. J Pain Symptom Manage. 1997, 14: 328-331. 10.1016/S0885-3924(97)00263-7.CrossRefPubMed
30.
go back to reference Gupta SC, Kim JH, Kannappan R, Reuter S, Dougherty PM, Aggarwal BB: Role of nuclear factor-κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents. Exp Biol Med. 2011, 236: 658-671. 10.1258/ebm.2011.011028.CrossRef Gupta SC, Kim JH, Kannappan R, Reuter S, Dougherty PM, Aggarwal BB: Role of nuclear factor-κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents. Exp Biol Med. 2011, 236: 658-671. 10.1258/ebm.2011.011028.CrossRef
31.
go back to reference Dodson S, Baracos VE, Jatoi A, Evans WJ, Cella D, Dalton JT, Steiner MS: Muscle Wasting in Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies. Annu Rev Med. 2011, 62: 265-279. 10.1146/annurev-med-061509-131248.CrossRefPubMed Dodson S, Baracos VE, Jatoi A, Evans WJ, Cella D, Dalton JT, Steiner MS: Muscle Wasting in Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies. Annu Rev Med. 2011, 62: 265-279. 10.1146/annurev-med-061509-131248.CrossRefPubMed
32.
go back to reference Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR: Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol. 2008, 26: 971-982. 10.1200/JCO.2007.10.7805.CrossRefPubMedPubMedCentral Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR: Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol. 2008, 26: 971-982. 10.1200/JCO.2007.10.7805.CrossRefPubMedPubMedCentral
33.
go back to reference Bourke L, Doll H, Crank H, Daley A, Rosario D, Saxton JM: Lifestyle Intervention in Men with Advanced Prostate Cancer Receiving Androgen Suppression Therapy: A Feasibility Study. Cancer Epidemiol Biomarkers Prev. 2011, 20: 647-657. 10.1158/1055-9965.EPI-10-1143.CrossRefPubMed Bourke L, Doll H, Crank H, Daley A, Rosario D, Saxton JM: Lifestyle Intervention in Men with Advanced Prostate Cancer Receiving Androgen Suppression Therapy: A Feasibility Study. Cancer Epidemiol Biomarkers Prev. 2011, 20: 647-657. 10.1158/1055-9965.EPI-10-1143.CrossRefPubMed
34.
go back to reference Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, Prud'Homme DG, Malone SC, Wells GA, Scott CG, Slovinec D'Angelo ME: Randomized Controlled Trial of Resistance or Aerobic Exercise in Men Receiving Radiation Therapy for Prostate Cancer. J Clin Oncol. 2009, 27: 344-350.CrossRefPubMed Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, Prud'Homme DG, Malone SC, Wells GA, Scott CG, Slovinec D'Angelo ME: Randomized Controlled Trial of Resistance or Aerobic Exercise in Men Receiving Radiation Therapy for Prostate Cancer. J Clin Oncol. 2009, 27: 344-350.CrossRefPubMed
35.
go back to reference Vignaroli EPE, Willey J, Palmer JL, Zhang T, Bruera E: The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med. 2006, 9 (2): 296-303. 10.1089/jpm.2006.9.296.CrossRefPubMed Vignaroli EPE, Willey J, Palmer JL, Zhang T, Bruera E: The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med. 2006, 9 (2): 296-303. 10.1089/jpm.2006.9.296.CrossRefPubMed
36.
go back to reference Butt Z, Wagner LI, Beaumont JL, Paice JA, Peterman AH, Shevrin D, Von Roenn JH, Carro G, Straus JL, Muir JC, Cella D: Use of a Single-Item Screening Tool to Detect Clinically Significant Fatigue, Pain, Distress, and Anorexia in Ambulatory Cancer Practice. J Pain Symptom Manage. 2008, 35: 20-30. 10.1016/j.jpainsymman.2007.02.040.CrossRefPubMed Butt Z, Wagner LI, Beaumont JL, Paice JA, Peterman AH, Shevrin D, Von Roenn JH, Carro G, Straus JL, Muir JC, Cella D: Use of a Single-Item Screening Tool to Detect Clinically Significant Fatigue, Pain, Distress, and Anorexia in Ambulatory Cancer Practice. J Pain Symptom Manage. 2008, 35: 20-30. 10.1016/j.jpainsymman.2007.02.040.CrossRefPubMed
37.
go back to reference Bernhard J, Sullivan M, Hürny C, Coates AS, Rudenstam CM: Clinical relevance of single item quality of life indicators in cancer clinical trials. Br J Cancer. 2001, 84: 1156-1165. 10.1054/bjoc.2001.1785.CrossRefPubMedPubMedCentral Bernhard J, Sullivan M, Hürny C, Coates AS, Rudenstam CM: Clinical relevance of single item quality of life indicators in cancer clinical trials. Br J Cancer. 2001, 84: 1156-1165. 10.1054/bjoc.2001.1785.CrossRefPubMedPubMedCentral
38.
go back to reference Locke DEC, Decker PA, Sloan JA, Brown PD, Malec JF, Clark MM, Rummans TA, Ballman KV, Schaefer PL, Buckner JC: Validation of Single-Item Linear Analog Scale Assessment of Quality of Life in Neuro-Oncology Patients. J Pain Symptom Manage. 2007, 34: 628-638. 10.1016/j.jpainsymman.2007.01.016.CrossRefPubMedPubMedCentral Locke DEC, Decker PA, Sloan JA, Brown PD, Malec JF, Clark MM, Rummans TA, Ballman KV, Schaefer PL, Buckner JC: Validation of Single-Item Linear Analog Scale Assessment of Quality of Life in Neuro-Oncology Patients. J Pain Symptom Manage. 2007, 34: 628-638. 10.1016/j.jpainsymman.2007.01.016.CrossRefPubMedPubMedCentral
39.
go back to reference Orre IJ, Reinertsen KV, Aukrust P, Dahl AA, Fosså SD, Ueland T: Murison R Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors. J Psychosom Res. 2011, 71: 136-141. 10.1016/j.jpsychores.2011.04.003.CrossRefPubMed Orre IJ, Reinertsen KV, Aukrust P, Dahl AA, Fosså SD, Ueland T: Murison R Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors. J Psychosom Res. 2011, 71: 136-141. 10.1016/j.jpsychores.2011.04.003.CrossRefPubMed
40.
go back to reference Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW: Inflammation and Behavioral Symptoms After Breast Cancer Treatment: Do Fatigue, Depression, and Sleep Disturbance Share a Common Underlying Mechanism?. J Clin Oncol. 2011, 29: 3517-3522. 10.1200/JCO.2011.36.1154.CrossRefPubMedPubMedCentral Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW: Inflammation and Behavioral Symptoms After Breast Cancer Treatment: Do Fatigue, Depression, and Sleep Disturbance Share a Common Underlying Mechanism?. J Clin Oncol. 2011, 29: 3517-3522. 10.1200/JCO.2011.36.1154.CrossRefPubMedPubMedCentral
Metadata
Title
Factors associated with the severity and improvement of fatigue in patients with advanced cancer presenting to an outpatient palliative care clinic
Publication date
01-12-2012
Published in
BMC Palliative Care / Issue 1/2012
Electronic ISSN: 1472-684X
DOI
https://doi.org/10.1186/1472-684X-11-16

Other articles of this Issue 1/2012

BMC Palliative Care 1/2012 Go to the issue